1. Home
  2. NRXP vs LGL Comparison

NRXP vs LGL Comparison

Compare NRXP & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • LGL
  • Stock Information
  • Founded
  • NRXP 2015
  • LGL 1917
  • Country
  • NRXP United States
  • LGL United States
  • Employees
  • NRXP N/A
  • LGL N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • LGL Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • LGL Technology
  • Exchange
  • NRXP Nasdaq
  • LGL Nasdaq
  • Market Cap
  • NRXP 32.6M
  • LGL 37.5M
  • IPO Year
  • NRXP N/A
  • LGL N/A
  • Fundamental
  • Price
  • NRXP $2.21
  • LGL $6.87
  • Analyst Decision
  • NRXP Strong Buy
  • LGL
  • Analyst Count
  • NRXP 4
  • LGL 0
  • Target Price
  • NRXP $28.50
  • LGL N/A
  • AVG Volume (30 Days)
  • NRXP 184.4K
  • LGL 5.7K
  • Earning Date
  • NRXP 05-15-2025
  • LGL 05-23-2025
  • Dividend Yield
  • NRXP N/A
  • LGL N/A
  • EPS Growth
  • NRXP N/A
  • LGL 59.20
  • EPS
  • NRXP N/A
  • LGL 0.08
  • Revenue
  • NRXP N/A
  • LGL $4,292,000.00
  • Revenue This Year
  • NRXP N/A
  • LGL N/A
  • Revenue Next Year
  • NRXP N/A
  • LGL N/A
  • P/E Ratio
  • NRXP N/A
  • LGL $82.50
  • Revenue Growth
  • NRXP N/A
  • LGL 16.69
  • 52 Week Low
  • NRXP $1.10
  • LGL $4.86
  • 52 Week High
  • NRXP $6.01
  • LGL $7.28
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 60.34
  • LGL 52.94
  • Support Level
  • NRXP $1.97
  • LGL $6.12
  • Resistance Level
  • NRXP $2.35
  • LGL $6.75
  • Average True Range (ATR)
  • NRXP 0.12
  • LGL 0.19
  • MACD
  • NRXP 0.03
  • LGL -0.03
  • Stochastic Oscillator
  • NRXP 75.28
  • LGL 77.60

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

Share on Social Networks: